Lilly Collaboration to Target Cancer Vaccines
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced a collaboration agreement with Germany-based CureVac AG. Lilly says the deal focuses on the development and commercialization of up to...... Read More
